Plain-English translation of NCT07915648 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
Pakistan
Phase
Post-approval monitoring
Sponsor
Nishtar Medical University
Enrollment target
~158 participants
Started
September 2026
Primary completion
March 2027
Age range
18 Years – 40 Years
Last updated on clinicaltrials.gov in November 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Muhammad T Suleman, MBBS
Nishtar Medical University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.